መነሻ › የበሽታ መከላከያ ሥርዓት እና ችግሮች › New York › New York City
በNew York City፣ NY ለየበሽታ መከላከያ ሥርዓት እና ችግሮች የሚደረጉ ክሊኒካዊ ጥናቶች
ለየበሽታ መከላከያ ሥርዓት እና ችግሮች የሚደረጉ 12 ጥናቶች በNew York City እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Memorial Sloan Kettering Cancer Center, New York
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Memorial Sloan Kettering Cancer Center, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Abatacept for the Treatment of Giant Cell Arteritis
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Hospital for Special Surgery, New York
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Icahn School of Medicine at Mount Sinai, New York
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Inmagene Site 21, New York
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Columbia University Irving Medical Center, New York
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Columbia University, New York
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Mt Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Biologics And Clinical Immunology Cohort at Sinai
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Mount Sinai, New York
በሌሎች ከተሞች ለየበሽታ መከላከያ ሥርዓት እና ችግሮች የሚደረጉ ጥናቶች
- Washington, DC13 ጥናቶች
- Philadelphia, PA10 ጥናቶች
- Boston, MA10 ጥናቶች
- Atlanta, GA9 ጥናቶች
- Portland, OR9 ጥናቶች
- Houston, TX9 ጥናቶች
- Los Angeles, CA8 ጥናቶች
- Cleveland, OH8 ጥናቶች
- Chicago, IL8 ጥናቶች
- Milwaukee, WI6 ጥናቶች
- Seattle, WA6 ጥናቶች
- Cedar Rapids, IA6 ጥናቶች
በNew York City ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር136 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር121 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)109 ጥናቶች
- የፕሮስቴት ካንሰር103 ጥናቶች
- Metastatic Cancer93 ጥናቶች
- የኮሎሬክታል ካንሰር78 ጥናቶች
- የእንቁላል ካንሰር69 ጥናቶች
- የሳንባ ካንሰር60 ጥናቶች
- Multiple Myeloma60 ጥናቶች
- የፓንክሪያስ ካንሰር60 ጥናቶች
- የኤንዶሜትሪየም ካንሰር52 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ51 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።